Tokuda K, Bodell W J
Department of Neurological Surgery, University of California, School of Medicine, San Francisco 94143.
Cancer Res. 1988 Jun 1;48(11):3100-5.
Rodent (9L and 9L-2) and human (SF-126 and SF-188) brain tumor cells were treated with methylating, ethylating, and chloroethylating nitrosoureas. 9L-2 and SF-188 cells were 10-fold and 5.4-fold more resistant to the cytotoxic effects of 1-(2-chloroethyl)-1-nitrosourea (CNU) than were 9L and SF-126 cells. SF-188 cells were 2.5- to 3-fold more resistant to N-methyl-N-nitrosourea (MNU) and streptozotocin (STZ) than SF-126 cells. 9L-2 cells were slightly more resistant to the cytotoxic effects of STZ and MNU than were 9L cells, but the rodent cells were 5- to 15-fold more resistant to these agents than the human cells. There were only small differences in cytotoxicity among the four cell lines after treatment with N-ethyl-N-nitrosourea (ENU). SF-188 and 9L-2 cells were 7- to 8-fold more resistant to the induction of sister chromatid exchange (SCEs) by CNU than were SF-126 and 9L cells. SF-126 cells were 80-fold more sensitive to the induction of SCEs by both STZ and MNU than were SF-188 cells. Only small differences in SCE induction were observed in 9L and 9L-2 cells treated with MNU and STZ. After ENU treatment, SF-126, 9L, and 9L-2 cells showed similar levels of SCEs; SF-188 cells were more resistant to the induction of SCEs by ENU. Pretreatment of 9L-2 cells with MNU resulted in a dose-dependent increase in cytotoxicity and SCE induction by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Treatment with 1 mM MNU completely reversed the cellular resistance of 9L-2 cells to BCNU but did not potentiate either cytotoxicity or SCE induction in 9L cells. These results suggest that O6-alkylguanine-DNA-alkyltransferase (O6-AT) plays an important role in determining the cytotoxicity of and the induction of SCEs by CNU in both rodent and human tumor cells. O6-AT may also influence the response of human cells to both the cytotoxic effects of and the induction of SCEs by MNU and STZ. In the rodent cells, however, biochemical mechanisms other than O6-AT appear to determine the cytotoxic response to these agents. O6-AT does not appear to influence the cytotoxicity of ENU in either human or rodent cells but may have a small effect on SCE induction in human cells.
用甲基化、乙基化和氯乙基化亚硝基脲处理啮齿动物(9L和9L-2)及人类(SF-126和SF-188)脑肿瘤细胞。9L-2和SF-188细胞对1-(2-氯乙基)-1-亚硝基脲(CNU)细胞毒性作用的抗性分别比9L和SF-126细胞高10倍和5.4倍。SF-188细胞对N-甲基-N-亚硝基脲(MNU)和链脲佐菌素(STZ)的抗性比SF-126细胞高2.5至3倍。9L-2细胞对STZ和MNU细胞毒性作用的抗性略高于9L细胞,但啮齿动物细胞对这些药物的抗性比人类细胞高5至15倍。用N-乙基-N-亚硝基脲(ENU)处理后,四种细胞系的细胞毒性仅有微小差异。SF-188和9L-2细胞对CNU诱导的姐妹染色单体交换(SCE)的抗性比SF-126和9L细胞高7至8倍。SF-126细胞对STZ和MNU诱导SCE的敏感性比SF-188细胞高80倍。在用MNU和STZ处理的9L和9L-2细胞中,仅观察到SCE诱导的微小差异。ENU处理后,SF-126、9L和9L-2细胞显示出相似水平的SCE;SF-188细胞对ENU诱导SCE的抗性更强。用MNU预处理9L-2细胞导致1,3-双(2-氯乙基)-1-亚硝基脲(BCNU)的细胞毒性和SCE诱导呈剂量依赖性增加。用1 mM MNU处理完全逆转了9L-2细胞对BCNU的细胞抗性,但未增强9L细胞的细胞毒性或SCE诱导。这些结果表明,O6-烷基鸟嘌呤-DNA-烷基转移酶(O6-AT)在决定CNU对啮齿动物和人类肿瘤细胞的细胞毒性及SCE诱导方面起重要作用。O6-AT也可能影响人类细胞对MNU和STZ的细胞毒性作用及SCE诱导的反应。然而,在啮齿动物细胞中,除O6-AT外的生化机制似乎决定了对这些药物的细胞毒性反应。O6-AT似乎不影响ENU对人类或啮齿动物细胞的细胞毒性,但可能对人类细胞中SCE诱导有微小影响。